Clover A1cTM Self --Glycosylated Hemoglobin Real-Time Detection System

As aging population appears and changes of lifestyle and food, diabetes mellitus has reached top-4 leading-cause of death in Taiwan. Diabetes is a systematic blood killer, which may cause complicated diseases including small vessel diseases (such as: retinal diseases, renal diseases, diseases of nervous system...etc). Blood sugar testing is an important part of diabetes care. While blood sugar tests usually detects the amount of short-term blood sugar, which can be easily affected by food, exercise, medications, and diseases. Detection of glycosylated proteins such as fructosamin, or especially glycosylated hemoglobin, is however, a more ideal way to monitor long-term level of blood sugar.

BioFirst has signed distribution agreement with Infopia from Korea as representative for CLOVER A1cTM Glycosylated Hemoglobin Real-Time Detection System. The product provides convenience of: within only 5 minutes and 3 simple steps, 4 μL of blood samples can be collected, and without pretreatment or cooling samples, blood sugar of patients with diabetes can be monitored and controlled without any interference by hemoglobin (Hb) variants. This technology reduces risks of complicated diseases and costs for medical care, as well as improving quality of life.